ArticleThe Lancet regional health. Europe2025
Care and outcomes of first-time myocardial infarction among vulnerable populations in Denmark, 2003-22: a nationwide registry-based cohort study.
Article in The Lancet regional health. Europe, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Care and Outcomes of New-Onset Heart Failure Across Vulnerable Populations: Temporal Trends in Mortality and Treatment in a Danish Nationwide Cohort From 2003 to 2022.Journal of the American Heart Association · 2026Article
- Assessing long-term temporal changes in myocardial infarction treatment and outcomes: chances and challenges.The Lancet regional health. Europe · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Mortality following a first-time myocardial infarction (MI) has declined, yet disparities in treatment and outcomes among potentially vulnerable groups remain unclear. We aimed to examine trends in treatment and mortality among first-time MI patients from 2003 to 2022 across eight potentially vulnerable subgroups in Denmark. Methods: Using Danish registries, patients with a first-time MI between 2003 and 2022 were identified and divided into five-year calendar groups and eight subgroups ('age ≥80', 'low income', 'female', 'frail', 'non-Western immigrant', 'history of mental illness', 'living alone', and 'living in a rural area'). Temporal trends in treatment initiation and mortality were assessed using Kaplan Meier estimates and multivariable Cox regression. Findings: Among 118,674 patients included, guideline-recommended therapy initiation increased over time, though gaps persisted (e.g. statin initiation in 2018-2022: 77.0% (2241/2911) among frail patients vs. 90.2% (19,986/22,157) among their counterparts). Crude and adjusted mortality rates declined for all subgroups over time, yet gaps persisted. Mortality remained highest among frail patients (5-year mortality risk of 48.7% [95% CI 46.5-50.9] in 2018-2022) and those aged ≥80 years (56.5% [95% CI 54.5-58.5]), no mortality difference was observed between patients living in rural areas and their counterparts (21.6% [95% CI 20.6-22.6] vs. 21.3% [95% CI 19.8-20.6] in 2018-2022), and non-Western immigrants exhibited lower mortality than their counterparts (8.8% [95% CI 7.0-10.6] vs. 21.3% [95% CI 20.7-22.0] in 2018-2022). Interpretation: Despite improvements from 2003 to 2022, persistent disparities underscore ongoing inequities and the need for targeted efforts to promote equity. Funding: None.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.